Search research articles

Renzo Colombo

1PUBLICATIONS

15CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 03, 2022

Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial.

Giuseppe Basile, Marco Bandini, Ewan A Gibb

Pageof 1

Frequent Collaborators

1 joint publications

Giuseppe Basile

1 joint publications

Marco Bandini

1 joint publications

Ewan A Gibb

1 joint publications

Jeffrey S Ross

1 joint publications

Daniele Raggi

1 joint publications

Laura Marandino

1 joint publications

Tiago Costa de Padua

1 joint publications

Emanuele Crupi

1 joint publications

Maurizio Colecchia

1 joint publications

Roberta Lucianò

Frequent Collaborators

1 joint publications

Giuseppe Basile

1 joint publications

Marco Bandini

1 joint publications

Ewan A Gibb

1 joint publications

Jeffrey S Ross

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos